Supporting Access, Enhancing Safety

For over two decades, Smartway has been supporting the NHS, private hospitals, pharmacies and clinics with the reliable supply of unlicensed medicines, particularly during times of medicine shortages and disruptions. Our expertise in sourcing and supplying unlicensed medicines has helped ensure continuity of care for patients when licensed alternatives are unavailable. With longstanding partnerships across the UK’s hospital network, we have played a key role in safeguarding access to vital treatments and reducing the burden on clinical teams navigating complex shortages.

As part of our ongoing commitment to medicine access and patient safety, we are excited to introduce SmartMed – our new portal designed to simplify and support the safe use of unlicensed medicines in clinical practice.

Introducing SmartMed – Built for Healthcare Professionals

Smartway are launching our own safety and risk assessment portal; SmartMed.

This powerful tool will provide quick and easy access to critical information on unlicensed medicines from Summary of Product Characteristics (SPCs) to pack shots to Certificates of Analysis (CoA’s). This will enable hospital pharmacists, technicians and clinicians to complete risk assessments with ease and allow for the safe implementation of unlicensed medicines within their practice.

With helpful additional functions such as market information regarding shortages and Active Pharmaceutical Ingredient (API) disruptions, we hope to provide more context and clarity to healthcare professionals to make better informed decisions when contemplating the necessity of unlicensed medicines for their patients. We have spent months researching and taking on board feedback from hospital colleagues on what they would like from a portal as a one-stop shop for all the necessary information to make their assessments more efficient to minimise the number of touch points between them and obtaining information.

We are confident that SmartMed encapsulates everything needed to assess unlicensed imports effectively and efficiently, with all relevant documents in one place for ease of access. The portal is designed to break down barriers, build confidence among healthcare professionals, and most importantly, help keep patients safe under our care.

“We understand the challenges healthcare professionals face when sourcing and assessing unlicensed medicines. SmartMed has been developed with their feedback at its core — to simplify access to essential information, reduce risk, and ultimately help deliver safe, timely care to patients.” – Amit Shah, Director of International Procurement

When Will Healthcare Professionals Be Able to Access SmartMed?

SmartMed is set to launch on 9th May 2025 at the market-leading Clinical Pharmacy Congress conference being held at ExCeL London, where healthcare professionals can come by our stand (F15) and ask our colleagues for a demonstration of our brand-new portal.

A Trusted Partner in a Complex Landscape

Unlicensed medicines remain a vital component of the NHS’s ability to respond quickly and effectively to patient needs. With decades of experience, Smartway continues to lead with experience, innovation and a strong sense of responsibility. SmartMed is the next step in our commitment to empower healthcare professionals with trusted tools and insight – helping ensure that every patient has access to safe treatment fast, even in the most challenging circumstances.

Learn how we support hopsitals and pharmacies in accessing unlicensed medicines.

For enquries about SmartMed, unlicensed medicines, or medicine shortages, please email [email protected].